The administration has been slow to address the opioid epidemic and the impact it’s had on families and communities, according to a group of advocacy groups.
But it has begun to roll back some of the Obama administration’s policies, including requiring insurers to cover a wide range of opioids, easing restrictions on prescription drug use, and expanding health insurance coverage to more people.
In the wake of a federal crackdown on opioid use in 2015, the White House and Congress have moved to expand access to opioid medications, while at the same time pushing to expand coverage for people who struggle with the drug.
That’s partly because some of Trump’s policies — including the loosening of restrictions on opioid prescriptions and increased spending on health care for low-income people — could hurt the opioid supply and drive up prices.
While Trump has been largely silent on the opioid issue, he has been supportive of some of Obama’s actions, including the federal government’s plan to give people on food stamps access to prescription drugs.
He has also embraced the idea of treating opioid addiction as a health problem, even while acknowledging that it is a problem that needs to be addressed.
Trump has taken several executive actions on the issue, including loosening restrictions on the use of prescription painkillers.
And he’s signed a slew of executive orders targeting opioid abuse and treatment.
The White House said it had no plans to reverse any of those actions, and some administration officials have said they are concerned that the opioid industry is not facing the same pressure as it did during the recession.
But the push to reduce opioid addiction and help the opioid addiction-related deaths have been met with skepticism by the industry, and experts say the industry is struggling to get the necessary funding.
The opioid epidemic is killing Americans and costing them their lives.
We must do everything we can to stop it.
President Donald Trump on Monday signed an executive order requiring drug manufacturers to make certain opioids are available for people on prescription medications.
The order is one of a series of initiatives the Trump Administration has launched over the past month to fight the opioid problem.
The administration is also moving to provide tax credits to help people pay for opioid prescriptions, and it is rolling back the Obama-era restrictions on insurance coverage for opioid addiction treatment.
On Monday, the Department of Health and Human Services (HHS) announced that it was ending a rule that limited coverage for treatment of opioid addiction for people under 65.
The policy, which was aimed at preventing the death of people in treatment, would be phased out by March 2020.
The Obama-Clinton administration had set up a new opioid prescription drug benefit that would allow people under age 65 to receive insurance coverage through Medicaid if they were on prescription drugs, as long as they had no prior opioid addiction or other substance abuse problems.
Under Trump’s order, the Obama program would no longer apply to people who are already insured under Medicaid, which is generally considered a government health care program.
That could be a big blow to the opioid treatment industry.
“What we need is a comprehensive approach to addressing the opioid drug crisis,” said John Hagee, president of the American Medical Association, a trade group.
“We need to give these people the same access to health care, treatment and recovery that all Americans have.”
Hagee said the opioid prescription pill industry was struggling with the opioid market.
“When they have that access, it’s going to be much more effective in helping people to get their lives back,” he said.
The drug industry has also been lobbying for federal funding to help fight the crisis, arguing that it could lead to more deaths.
The industry also has been lobbying to make opioid abuse treatment as affordable as possible, saying that more people are dying of the opioid than people are recovering from the overdose.
The Trump administration is not taking the industry’s concerns lightly, and on Tuesday, the administration announced that the Centers for Medicare and Medicaid Services would begin a pilot program to assess the effectiveness of providing access to emergency drug treatment to people in the opioid-dependent population.
The Centers for Medicaid and Medicare Services is conducting the pilot program under the name of Access to Drug Free Communities, a program that will focus on the costs associated with opioid addiction treatments, such as opioid addiction counseling, addiction treatment and opioid medication.
The pilot program will test whether it is cost effective and will look at the effectiveness in the communities served by the participating counties.
In a statement, the Centers said that the pilot would “assess the effectiveness, safety and affordability of opioid treatment programs in the community, as well as the impact on health outcomes.”HHS spokeswoman Stephanie Schriock said the pilot will be conducted with the goal of providing coverage for patients who are on prescription opioids and who have not yet enrolled in an opioid treatment program, but did not elaborate.
“The pilot will begin as soon as possible and will determine if the pilot can serve as a model for the rest of the nation,” Schriok said.
She said that under the pilot, insurance companies will not be able to deny coverage to people with existing medical conditions